Stay updated on Amivantamab Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision history was updated with a new Revision: v3.6.6 and August 2026 entries, replacing July 2026 entries, and an NIH grant/contract note from 2018 was added.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays a 500 internal server error page indicating the requested study record is currently unavailable, replacing the usual study content with an error message.SummaryDifference16%

- Check51 days agoChange DetectedThe change represents an incremental platform update from v3.6.3 to v3.6.4. There is no indication of changes to the trial information or page layout.SummaryDifference0.0%

- Check58 days agoChange DetectedA CHRYSALIS-related publication citation has been added to the Publications section, expanding the literature cited for Amivantamab in NSCLC. The change does not modify study details or reporting on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded July 2026 update dates to the page's update history (2026-07-06, 2026-07-02, 2026-07) and removed June 2026 dates (2026-06-05, 2026-06-04, 2026-06).SummaryDifference0.1%

- Check73 days agoChange DetectedA new reference about amivantamab-related cutaneous toxicities has been added to the page. The page revision tag has been updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.